Clinical trial Recruiting at 1 site Observational Ages 18 and up

PERC and YEARS approaches for diagnosing pulmonary embolism in the emergency department.

Official title: Evaluation of the PERC Score and the YEARS Algorithm in the Diagnosis of Pulmonary Embolism in the Emergency Department: a Retrospective Observational Study in the Emergency Department of the Strasbourg University Hospital

Run by University Hospital, Strasbourg, France · NCT07313501 · Data updated 2026-11-12

This project will test whether using the PERC score and the YEARS algorithm helps emergency doctors decide which adults need D-dimer blood tests or chest CT scans to diagnose pulmonary embolism.

More Pulmonary Embolism trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorUniversity Hospital, Strasbourg, France
Academic / other
Locations1 site (Strasbourg)
StatusRecruiting
StartedFebruary 26, 2025
Main results expectedFebruary 2026
Study endsFebruary 2026
Registry record updatedJanuary 2, 2026
Trial IDNCT07313501 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) presenting to the Strasbourg University Hospital emergency department with suspected pulmonary embolism who had D-dimer testing and chest imaging performed are the ideal candidates.

Probably not a fit

Patients on long-term anticoagulation, those without D-dimer testing or chest imaging, or individuals whose presentation clearly requires imaging are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Current diagnosis of pulmonary embolism typically uses clinical judgment followed by D-dimer testing and chest CT angiography, which can lead to overuse of imaging. The PERC rule and the YEARS algorithm are clinical decision tools designed to stratify risk and reduce unnecessary imaging by guiding when D-dimer or CT should be used. This observational analysis will include adults (≥18 years) seen in the Strasbourg University Hospital emergency department from January to June 2024 who had D-dimer testing and chest imaging, and will apply PERC and YEARS to those encounters. Main outcomes include potential reductions in CT angiography use, changes in emergency department waiting times, and the diagnostic yield of imaging when these algorithms are applied.

Why it matters

Potential benefit: If successful, this approach could reduce unnecessary CT scans, lower radiation exposure, and shorten emergency department wait times.

How similar studies have gone: Previous research has shown that both PERC and YEARS can safely reduce imaging use in some settings, though results vary by population and implementation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient (≥18 years)
* Patient admitted to the adult emergency department of the Strasbourg University Hospital over a 6-month period (January to June 2024), for whom a D-dimer test and chest imaging (thoracic CT angiography or ventilation/perfusion scintigraphy) were performed

Exclusion Criteria:

\- No D-dimer test or test performed for another indication, no chest imaging (CT angiography or scintigraphy), long-term anticoagulant treatment.

Where it's running

  • Service d'Urgences Médico-Chirurgicales Adules - CHU de Strasbourg - France
    Strasbourg, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.